Mounjaro and under-18s: what the licence says and what to do instead

You've heard Mounjaro works for adults, here's why that doesn't extend downward

A parent searching this question has usually watched their child struggle with weight for years, tried every conventional route, and seen an adult relative lose significant weight on tirzepatide. The logic (why wouldn't it help a teenager too) is human and entirely reasonable. The short answer is that medicines are licensed for specific populations based on the clinical trials that were run, and the SURMOUNT trials that underpinned Mounjaro's UK approval enrolled adults only. The NHS medicines page for tirzepatide is clear: it is not recommended for people under 18 years of age.

That isn't a bureaucratic technicality. Adolescent physiology differs from adult physiology in ways that matter for a medicine acting on gut hormones, appetite regulation, and energy metabolism. Growth, bone density, and hormonal development are all active in teenagers. Without trial data in this group, a prescriber cannot weigh benefit against risk in any meaningful way. Prescribing off-licence to a minor in these circumstances would be a serious departure from safe practice, and no responsible UK prescriber would do it.

The same position holds for the wider class. The NHS semaglutide page carries an identical under-18 exclusion for Wegovy. This is not a gap that a private prescription fills.

What actually is available for young people with weight-related health concerns

The NHS does have pathways for children and teenagers with obesity or weight-related conditions, they just look very different from adult weight management services. Specialist paediatric services, usually accessed via GP referral, can assess a young person properly and consider a broader range of interventions: structured lifestyle programmes, dietitian support, psychological input, and, in some cases, medicines specifically studied in adolescents. Orlistat has a limited evidence base in adolescents and is occasionally used under specialist supervision, though it is not routinely recommended. Bariatric surgery is exceptionally rare in under-18s and requires specialist ethics oversight.

If a teenager has been diagnosed with type 2 diabetes, that changes the conversation, but it remains a paediatric endocrinology question, not an adult weight-loss medicine question. Our weight-loss treatment overview covers the adult landscape, which is useful background, but the starting point for a young person is a GP referral to the appropriate paediatric team.

For adults who are just turning 18 and wondering when they might be eligible, the licence requires being 18 at the time of assessment. A consultation booked the Monday after an 18th birthday (first payday, say, or after the summer holidays when life settles down) would be the earliest point a prescriber could properly consider it. Timing aside, eligibility still depends on BMI, health history, and clinical judgement, as it does for any adult.

The safety considerations that shape this rule

Some parents ask whether there is any grey area, a compassionate exception, a specialist who might consider it. There isn't, within legitimate UK prescribing. The NICE appraisal of tirzepatide (TA1026) specifies adults throughout; the SmPC lists under-18 as a contraindication rather than a caution. A contraindication is not a starting point for negotiation.

Thyroid history is worth noting here too. Tirzepatide carries a precaution around a history of medullary thyroid carcinoma, which overlaps with MEN2 syndrome, conditions that can present in younger patients. If a young person has any thyroid history, that conversation belongs with an endocrinologist regardless of age. Our page on Mounjaro and thyroid conditions covers the adult picture, which is useful context for anyone in the family.

For adults considering their own treatment, the cardiovascular considerations are also well-documented, our Mounjaro and heart health page covers what the evidence shows in adults with cardiovascular risk factors. Adults who are older or who have questions about how age intersects with eligibility can also read our guidance on Mounjaro use in elderly patients, which covers the additional clinical factors a prescriber will weigh. Liver health is another area that comes up in adult assessments, and our page on Mounjaro and the liver explains what the current evidence says for adults with relevant history. For anyone who is pregnant or planning a pregnancy, our page on Mounjaro and pregnancy sets out why treatment is not appropriate during this period and what to do instead.

What to do next if you're an adult ready to explore your own options

If you're an adult reading this after clarifying the position for a family member, and you're considering whether Mounjaro might be appropriate for you, the process at nume is straightforward. A guide to obtaining Mounjaro through a legitimate UK route covers what to expect. Everything begins with a free consultation, reviewed the same working day by a GPhC-registered prescriber, a real clinician reading your answers, not an automated screen. You can verify our pharmacy on the GPhC register, premises number 9012878.

For anyone with questions about specific health situations and how they interact with treatment, our FAQs are a reasonable first stop, and our team is reachable via our contact page if you'd prefer to ask directly. Adult eligibility, clinical suitability, and next steps are decisions made with our prescribers, not in advance of the consultation.

Start your free consultation if you're an adult exploring whether treatment is right for you.